title: Fas gene mutation in the progression of adult T cell leukemia.
abstract: Fas antigen (Apo-1/CD95) is an apoptosis-signaling cell surface receptor belonging to the tumor necrosis factor receptor superfamily. Adult T cell leukemia (ATL) cells express Fas antigen and show apoptosis after treatment with an anti-Fas monoclonal antibody. We established the ATL cell line KOB, which showed resistance to Fas-mediated apoptosis, and found that KOB expressed two forms of Fas mRNA, the normal form and a truncated form. The truncated transcript lacked 20 base pairs at exon 9, resulting in a frame shift and the generation of a premature stop codon at amino acid 239. The same mutation was detected in primary ascitic cells and peripheral blood cells. The mutation was not detected in lymph node cells, however, although all of the primary ATL cells were of the same clonal origin. A retroviral-mediated gene transfer of the truncated Fas to Jurkat cells rendered the cells resistant to Fas-mediated apoptosis, suggesting a dominant negative interference mechanism. These results indicate that an ATL subclone acquires a Fas mutation in the lymph nodes, enabling the subclone to escape from apoptosis mediated by the Fas/Fas ligand system and proliferate in the body. Mutation of the Fas gene may be one of the mechanisms underlying the progression of ATL.
authors: Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Aichi 464-0221, Japan. tmaeda@net.nagasaki-u.ac.jp
authors: T
authors: T
authors: Maeda
authors: Y
authors: Y
authors: Yamada
authors: R
authors: R
authors: Moriuchi
authors: K
authors: K
authors: Sugahara
authors: K
authors: K
authors: Tsuruda
authors: T
authors: T
authors: Joh
authors: S
authors: S
authors: Atogami
authors: K
authors: K
authors: Tsukasaki
authors: M
authors: M
authors: Tomonaga
authors: S
authors: S
authors: Kamihira
mesh_terms: D000368:Aged; D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D017209:Apoptosis; D001201:Ascites / Q000473:pathology; D001483:Base Sequence; D018450:Disease Progression; D005091:Exons / Q000235:genetics; D017809:Fatal Outcome; D016368:Frameshift Mutation; D015333:Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; D015368:Human T-lymphotropic virus 1 / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D007075:Immunoglobulin M / Q000494:pharmacology; D019169:Jurkat Cells; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000235:genetics* / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D008969:Molecular Sequence Data; D009360:Neoplastic Cells, Circulating; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014162:Transfection; D014407:Tumor Cells, Cultured; D019014:fas Receptor / Q000235:genetics* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D007075:Immunoglobulin M; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D019014:fas Receptor